Novel Sickle Cell Treatment Among 13 New Drugs On Track For EU Approval

A first-of-its-kind drug for uterine fibroids and a new monoclonal antibody treatment for COVID-19 are among several new drugs recommended for pan-EU approval this month.

Thumbs up
Several New Medicines Have Got The Thumbs Up From The EMA • Source: Alamy

The European Medicines Agency has recommended for EU-wide approval 13 new medicines, including two orphans - Global Blood Therapeutics’ first-in-class therapy for sickle cell disease Oxbryta (voxelotor), and Pfizer/Opko Health’s treatment for growth hormone deficiency Ngenla (somatrogon).

The EMA has also recommended for pan-EU approval ObsEva’s Yselty (linzagolix choline), which the company says is a first-of-its-kind...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography